The Company updated its guidance as well as its assumptions underlying that guidance for the year ended December 3 previously provided on February 28..Challenges to consumer spending and sustained high inflation continue to impact overall expected demand in 2023 for SDC‘s core business. The full year 2023 costs and capital outlook now includes contributions from the 2023 rollout of the SmileMaker Platform and launch of the CarePlus solution which the Company continues to scale and will contribute to financial results in the back half of the year.. Sees FY 23 adjusted EBITDA($40M) to ($10M).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SDC:
- SmileDirectClub options imply 22.7% move in share price post-earnings
- Largest borrow rate increases among liquid names
- SmileDirectClub opens 8 new SmileShops, partners with Therapie Clinic
- SmileDirectClub Partners With Leading Medical Aesthetic Provider Thérapie Clinic To Expand SmileShop Reach In UK and Ireland
- SmileDirectClub expands new premium CarePlus offering